Literature DB >> 6139028

Psammomatous somatostatinomas of the duodenum.

Y Dayal, W G Doos, M J O'Brien, G Nunnemacher, R A DeLellis, H J Wolfe.   

Abstract

The presence of psammoma bodies in carcinoid tumors of the gastrointestinal tract is a rare occurrence; it has also been reported to be associated with features of somatostatin production by the tumor cells. The morphologic features of three such tumors arising in the duodenum were studied by a combination of histochemical, immunocytochemical, and ultrastructural techniques in an effort to delineate their secretory profile and further subclassify them. All tumors showed a mixed architectural pattern with prominent areas of glandular differentiation. The psammoma bodies were almost exclusively located within the glandular lumina. In each instance, the majority of tumor cells showed histochemical and immunocytochemical features of somatostatin-containing cells, and one tumor studied ultrastructurally showed numerous large- and small-sized intracytoplasmic secretory granules, both of which contained somatostatin. In contrast to other endocrine tumors of the duodenum that frequently have a multihormonal secretory profile, psammomatous duodenal carcinoids are associated with the exclusive presence of somatostatin within tumor cells. While many more of such examples of this uncommon tumor need to be systematically investigated for their immunocytochemical and ultrastructural characteristics, duodenal somatostatinomas need to be included in the differential diagnosis of psammomatous tumors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139028     DOI: 10.1097/00000478-198310000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

1.  Psammomatous carcinoid of the rectum.

Authors:  S A Pai; D Kini; K Shetty; U V Rao
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

Review 2.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Duodenal carcinoid in neurofibromatosis: a calcitonin- and amyloid-containing tumor.

Authors:  Z Posalaky; M Mulholland; E Kasperson; I P Posalaky
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

4.  Histopathology, hormone products, and clinicopathological profile of endocrine tumors of the upper small intestine: A study of 44 cases.

Authors:  Carlo Capella; Cristina Riva; Guido Rindi; Fausto Sessa; Luciana Usellini; Annamaria Chiaravalli; Luciano Carnevali; Enrico Solcia
Journal:  Endocr Pathol       Date:  1991-06       Impact factor: 3.943

5.  Ampullary neurofibroma.

Authors:  T C Simmons
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

Review 6.  [Neuroendocrine tumors of the gastrointestinal tract].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

7.  Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN I syndrome and von Recklinghausen's disease (neurofibromatosis).

Authors:  B Stamm; C E Hedinger; P Saremaslani
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

8.  Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.

Authors:  A G Fahrenkamp; C Wibbeke; G Winde; D Ofner; W Böcker; R Fischer-Colbrie; K W Schmid
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 9.  [Von Recklinghausen type I neurofibromatosis and neuroendocrine tumor (somatostatinoma) in a 50-year-old woman].

Authors:  M Reichardt; W Rexroth; C Hasslacher
Journal:  Med Klin (Munich)       Date:  1998-09-15

Review 10.  Endocrine cells producing regulatory peptides.

Authors:  E Solcia; L Usellini; R Buffa; G Rindi; L Villani; C Zampatti; E Silini
Journal:  Experientia       Date:  1987-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.